Yahoo Web Search

Search results

1. investors.vrtx.comInvestor Relations | Vertex Pharmaceuticals

   investors.vrtx.com

   • Cached

   1 day ago · Vertex is a biotechnology company focused on developing and commercializing treatments for serious diseases. Find out its latest financial results, events, presentations, and stock information.

2. finance.yahoo.com › news › everyones-talking-vertexEveryone's Talking About Vertex Pharmaceuticals. Is It Time to...

   finance.yahoo.com › news › everyones-talking-vertex

   • Cached

   4 days ago · VRTX. Vertex Pharmaceuticals (NASDAQ: VRTX) recently excited the medical community with clinical trial results from an experimental diabetes treatment it's developing. In a nutshell, it looks like ...

3. Videos

   • 

     2:11

     youtube.com

     The History and Future of Vertex Pharmaceuticals | Vertex Pharmaceuticals

     14 May 2021

     12.9K views

   • 

     2:36

     youtube.com

     Innovation is Our Lifeblood | Vertex Pharmaceuticals

     16 May 2024

     151 views

   • 

     3:15

     youtube.com

     Fearless Pursuit of Excellence | Vertex Pharmaceuticals

     5 Mar 2024

     45 views

   View all

4. investors.vrtx.com › press-releasesPress Releases | Vertex Pharmaceuticals

   investors.vrtx.com › press-releases

   • Cached

   Jun 7, 2024 · Vertex Pharmaceuticals is a biotechnology company developing treatments for cystic fibrosis, sickle cell disease, beta thalassemia, pain and kidney disease. Read the latest press releases and news about its financial results, clinical trials, approvals, collaborations and acquisitions.

5. www.bloomberg.com › quote › VRTX:USVRTX: Vertex Pharmaceuticals Inc Stock Price Quote - Bloomberg

   www.bloomberg.com › quote › VRTX:US

   • Cached

   3 days ago · Stock analysis for Vertex Pharmaceuticals Inc (VRTX:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

   • Employees: 5.4K

6. Top stories

   • 

     MarketWatch

     Vertex Pharmaceuticals Inc. stock underperforms Friday when compared to competitors

     8 hours ago

   • 

     Yahoo Finance

     Vertex (VRTX) Rises 16.5% YTD: Time to Bet On the Stock?

     2 days ago

   • 

     The Motley Fool

     Everyone's Talking About Vertex Pharmaceuticals. Is It Time to Buy?

     4 days ago

   • bovnews

     Redburn Atlantic Sets Vertex Pharmaceuticals, Inc. (NASDAQ:VRTX) Stock to “a Buy”

     Redburn Atlantic raised the price target for the Vertex Pharmaceuticals, Inc. (NASDAQ:VRTX) stock to “a Buy”. The rating was released on Jun-28-24, according to finviz. The research report from Wolfe Research has initiated the stock to Outperform,

     8 hours ago

   • YAHOO!Finance

     Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It

     Vertex (VRTX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

     3 days ago

   View all

7. markets.businessinsider.com › news › stocksVertex Pharmaceuticals’ VX-880 Shows Promise in T1D Treatment...

   markets.businessinsider.com › news › stocks

   • Cached

   2 days ago · Vertex Pharmaceuticals (VRTX) Company Description: Based in Massachusetts and incorporated in 1989, Vertex Pharmaceuticals, Inc. is a biopharmaceutical company, which is engaged in the development ...

8. investors.vrtx.com › news-releases › news-release-detailsNews & Events - Vertex Pharmaceuticals

   investors.vrtx.com › news-releases › news-release-details

   • Cached

   2 days ago · Vertex and CRISPR Therapeutics Announce Global exa-cel Regulatory Submissions for Sickle Cell Disease and Beta Thalassemia in 2022. - Exa-cel will be submitted to the U.S. FDA for rolling review beginning in November, with completion of the U.S. submission package in Q1 2023 - - EMA and MHRA submissions are on track for Q4 2022 -

9. finance.yahoo.com › news › vertex-pharmaceuticals-incorporatedIs Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) the Leading...

   finance.yahoo.com › news › vertex-pharmaceuticals-incorporated

   • Cached

   Jun 3, 2024 · “Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) develops drugs for treating cystic fibrosis, cancer, inflammatory bowel, autoimmune disease and neurological disorders.